Neuro-cosmeceuticals represent a transformative convergence of neurobiology, dermatology, and cosmetic science, redefining skincare through the lens of the brain–skin axis. Far beyond conventional topical formulations, this emerging domain recognizes the skin as an active neuro-immuno-endocrine interface capable of both perceiving and transmitting biochemical signals to the central nervous system. The bidirectional communication between the brain and skin is orchestrated through intricate pathways involving the hypothalamic–pituitary–adrenal (HPA) axis, peripheral nerve endings, neuropeptides, and cytokines, forming a dynamic feedback loop where psychological states directly influence cutaneous physiology. Emotional stress, a key modulator within this axis, stimulates the release of cortisol and pro-inflammatory mediators, leading to compromised skin barrier integrity, dysregulated sebum production, delayed wound healing, and the exacerbation of conditions such as acne, psoriasis, eczema, and premature aging. Neuro-cosmeceuticals strategically target this neurocutaneous interplay by incorporating bioactive compounds that modulate neurotransmitter activity, attenuate stress responses, and restore skin homeostasis. Advanced delivery systems further enhance their efficacy by enabling precise interaction with cutaneous nerve receptors, facilitating localized neuro-modulation without systemic side effects. By addressing both emotional dysregulation and dermatological dysfunction simultaneously, neuro-cosmeceuticals introduce a paradigm shift toward holistic, emotion-responsive skincare. This integrative approach not only improves therapeutic outcomes but also aligns with the evolving consumer demand for wellness-driven solutions that bridge mental well-being and visible skin health, positioning neuro-cosmeceuticals as a cornerstone of next-generation, personalized dermatological therapy.
Nisha Choudhary*, Paritosh Patel, Kalyani Chande (Sat,) studied this question.